[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 92
Citations 0
In This Issue of JAMA Oncology
February 2020


JAMA Oncol. 2020;6(2):171. doi:10.1001/jamaoncol.2019.4202

Mohile and colleagues performed a cluster-randomized clinical trial that enrolled 541 participants 70 years or older from 31 community oncology practices. Practices were randomized to receive a geriatric assessment summary with recommendations for each patient (intervention) or alerts only for patients with depression or cognitive impairment (usual care). The findings suggest that use of a geriatric assessment improves communication about aging-related concerns. Biganzoli and colleagues provide an Invited Commentary.

Invited Commentary

This meta-analysis by Terrisse and colleagues for the MORPHEP Collaborative Group compared bone-targeted radioisotope use with no radioisotope use among 2081 patients with castration-resistant prostate cancer. The analysis showed a significant improvement in overall survival and symptomatic skeletal free-survival with bone-targeted α-emitting, but not β-emitting, radioisotopes. Swami and colleagues provide an Invited Commentary.